Related Experiment Videos
Epitopes and idiotypes in experimental autoimmune uveitis: a review
H S Dua1, M Abrams, J A Barrett
1Research Division, Wills Eye Hospital, Philadelphia.
Current Eye Research
|January 1, 1992
Summary
Researchers discovered a dominant "tolerogenic" epitope in retinal S-antigen (SAg), crucial for understanding autoimmune diseases like uveitis. This finding also revealed cross-reactive epitopes and a unique antibody targeting SAg.
Area of Science:
- Immunology
- Ophthalmology
- Autoimmune Diseases
Background:
- Experimental autoimmune uveitis (EAU) and experimental autoimmune pinealitis (EAP) induced by retinal S-antigen (SAg) and interphotoreceptor retinol-binding protein (IRBP) serve as valuable models for autoimmune disease mechanisms.
- While numerous immunogenetically active epitopes within SAg and IRBP have been identified, their in vivo immunodominance remains unestablished.
Purpose of the Study:
- To identify and characterize dominant epitopes in SAg and IRBP involved in autoimmune responses.
- To investigate cross-reactivity between epitopes of SAg and IRBP.
- To explore the characteristics of a novel anti-idiotypic monoclonal antibody (MAb).
Main Methods:
- Induction of EAU and EAP in animal models.
- Epitope mapping and identification using immunological assays.
- Analysis of cross-reactivity between retinal antigens.
- Characterization of anti-idiotypic monoclonal antibodies (MAbs).
Main Results:
- Discovery of a dominant "tolerogenic" epitope within SAg.
- Demonstration of cross-reactive epitopes shared by SAg and IRBP.
- Preliminary data on a unique anti-idiotypic (Id) monoclonal antibody (MAb) that binds to both an idiotype (s2.4.c5) and SAg.
Conclusions:
- A dominant tolerogenic epitope in SAg has been identified, offering potential therapeutic targets for autoimmune uveitis.
- Cross-reactivity between SAg and IRBP epitopes suggests shared mechanisms in autoimmune responses.
- The characterized anti-idiotypic MAb may provide insights into immune regulation and antigen recognition in autoimmune diseases.